Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06542133 · ClinicalTrials.gov registry record
AVEIR Remote Care System Non-Significant Risk Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 32
- Enrollment target
NCT06542133: Completed study, sponsored by Abbott Medical Devices.
NCT06542133 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06542133 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The goal of the study is to understand the performance of the AVEIR Remote Care System in an initial patient cohort which will inform the ability to offer a remote follow-up solution to all patients implanted with Aveir LP devices.
Primary Outcome
Successful transmission performance metrics of the AVEIR Remote Care System in approximately 32 subjects who have received an Aveir LP implanted system as part of their standard of care.
Interventions
- DEVICE AVEIR remote care system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-06-10 |
| Est. Completion | 2024-08-30 |
What the finished NCT06542133 record still lists
NCT06542133 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which AVEIR remote care system is the first listed.
NCT06542133 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06542133 about?
NCT06542133 is a clinical study titled "AVEIR Remote Care System Non-Significant Risk Study". The goal of the study is to understand the performance of the AVEIR Remote Care System in an initial patient cohort which will inform the ability to offer a remote follow-up solution to all patients implanted with Aveir LP devices.
What is the current status of trial NCT06542133?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2024-06-10. Estimated completion is 2024-08-30.
What interventions are being tested in trial NCT06542133?
The interventions under investigation include: AVEIR remote care system (DEVICE).
Who is sponsoring clinical trial NCT06542133?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI